Ceragenix Pharmaceuticals Inc (OSCE)

Stock chart
Ticker: OSCE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
OSMOTICS CORP
1 sale — total 15,000 USD
Sale 9 Mar 2010
Value US$1,583,256.28 | Price 476.64 | Shares 22,780
Sale 31 Aug 2007
Value US$3,022,036.58 | Price 217.59 | Shares 13,734
Sale 14 Aug 2007
Value US$12,500.00 | Price 1.25 | Shares 10,000
Sale 27 Jun 2007
Value US$75,000.00 | Price 1.50 | Shares 50,000
Sale 9 May 2007
Value US$82,500.00 | Price 1.65 | Shares 50,000
Buy 18 Aug 2006
Value US$21,000.00 | Price 2.10 | Shares 10,000
Sale 11 May 2006
Value US$300,000.00 | Price 2.00 | Shares 150,000
Buy 22 Oct 2004
Value US$1,620.00 | Price 0.60 | Shares 2,700
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2010-03-11 2010-03-09 S Sale OSMOTICS CORP Large shareholder
22,780 -11.5%
476.64
US$1,583,256
22,780 -11.5% 476.64 US$1,583,256
2007-08-31 2007-08-31 S Sale OSMOTICS CORP Large shareholder
13,734 -13.6%
217.59
US$3,022,037
13,734 -13.6% 217.59 US$3,022,037
2007-08-16 2007-08-14 S Sale OSMOTICS CORP Large shareholder
61,067 -25.5%
99.97
US$3,056,369
61,067 -25.5% 99.97 US$3,056,369
2007-06-29 2007-06-27 S Sale OSMOTICS CORP Large shareholder
50,000 -0.5%
1.50
US$75,000
50,000 -0.5% 1.50 US$75,000
2007-05-11 2007-05-09 S Sale OSMOTICS CORP Large shareholder
50,000 -0.5%
1.65
US$82,500
50,000 -0.5% 1.65 US$82,500
2006-08-22 2006-08-18 B Purchase ALLEN RUSSELL L

VP Corporate Development

Officer
10,000 +5000.0%
2.10
US$21,000
10,000 +5000.0% 2.10 US$21,000
2006-05-12 2006-05-11 S Sale OSMOTICS CORP Large shareholder
150,000 -1.3%
2.00
US$300,000
150,000 -1.3% 2.00 US$300,000
2004-10-26 2004-10-22 B Purchase OVERTURF JOHN R JR
2,700 +22.5%
0.60
US$1,620
2,700 +22.5% 0.60 US$1,620
Explore more

More insider trading research around Ceragenix Pharmaceuticals Inc